Clinical evaluation of different varieties of Trivrut on Constipation

A pharmaco-clinical study on source drugs of Trivrut

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2014/10/005119

Enrollment

Registered

2014-10-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- suffering from Constipation

Interventions

Intervention1: Operculina turpethum: root bark powder of Operculina turpethum in the dose of 5 gm once in a day in the morning for 7 days Control Intervention1: Operculina petaloidea: root bark powde

Eligibility

Inclusion criteria

Inclusion criteria: Patients with classical symptoms of Purishaja Anaha Patients having complaints of irregular and unsatisfactory bowel motions will be selected irrespective of sex religion from OPD of dravyaguna department

Exclusion criteria

Exclusion criteria: Patients suffering from any systemic disease like Hypertension Diabetes TB etc Pregnant woman Patients unsuitable for virechana

Design outcomes

Primary

Measure	Time frame
everyday,In the frequency and consistency of stoolTimepoint: Baseline and every day for 7 days	—

Secondary

Measure	Time frame
Symptomatic relief in associated symptoms of constipationTimepoint: 3 days	—

Countries

India

Contacts

Public ContactDr R N Acharya

Institute for post graduate teaching and research in ayurveda

drrnacharya@gmail.com9924585855

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026